000 01176 a2200349 4500
005 20250512093246.0
264 0 _c19700305
008 197003s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(70)90634-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParkes, J D
245 0 0 _aControlled trial of amantadine hydrochloride in Parkinson's disease.
_h[electronic resource]
260 _bLancet (London, England)
_cFeb 1970
300 _a259-62 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAmantadine
_xadverse effects
650 0 4 _aChlorides
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aMotor Activity
650 0 4 _aMovement
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aPlacebos
700 1 _aCalver, D M
700 1 _aZilkha, K J
700 1 _aKnill-Jones, R P
773 0 _tLancet (London, England)
_gvol. 1
_gno. 7641
_gp. 259-62
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(70)90634-3
_zAvailable from publisher's website
999 _c4194666
_d4194666